We examined whether APOE-ε3 vs ε4 genotypes would affect expression levels of CACNB4 in human AD patient brains, based on a previously published single-nuclei RNA sequencing dataset by Haney et al26. The gene discussed is CACNB4; the disease is Alzheimer disease.